期刊文献+

心肌纤维化大鼠Intermedin_(1-53)及其受体的变化 被引量:1

The Expression of Intermedin_(1-53) and IMD_(1-53) Receptors in Hearts of Myocardial Fibrosis Rats
下载PDF
导出
摘要 目的在大鼠心肌梗死致心肌纤维化模型上观察Intermedin1-53及其受体的变化。方法通过结扎左冠状动脉前降支制备大鼠心肌梗死模型,4周后检测心功能,梗死区心肌组织的Ⅰ、Ⅲ型胶原蛋白表达,IMD1-53和心室肌降钙素受体样受体(CL)、受体活性修饰蛋白(RAMP)1/2/3的mRNA表达。结果与假手术组比较模型组大鼠的心功能明显减低,检测梗死区心肌组织的Ⅰ、Ⅲ胶原蛋白表达增加,心室肌IMD1-53、CL、RAMP1/2/3的mRNA水平分别上调75%(P<0.01)、57%(P<0.05)、61%(P<0.01)、48%(P<0.05)和80%(P<0.05)。结论心肌纤维化大鼠的心肌IMD1-53及其受体明显上调,其变化可能参与心肌纤维化的发病过程。 Objective To observe the gene expression of IMD1-53 and IMD1-53 receptors in the myocardial fibrosis rats reduced by myocardial infarction. Methods Rats with Acute myocardial infarction (AMI) were induced by left anterior descending coronary branch ligation. The cardiac function was measured The protein levels of type Ⅰ and Ⅲ collagen were assayed by Western blotting and the mRNA levels of IMD1-53, CL, RAMP1,2, 3 were determined by semi - quantitative RT - PCR in the infracted hearts after 4 weeks of operation. Results Compared with the sham -operated group, cardiac function significantly decreased, protein levels of type Ⅰ and Ⅲ collagen significantly increased and the mRNA levels of CL, RAMP1, RAMP2 and RAMP3 significantly elevated by 75% (P〈0.01), 57% (P〈0.05), 61% (P〈0.01), 48% (P〈0.05) and 80% (P 〈 0.05) respectively in myocardial fibrosis rat. Conclusion The results suggest that IMD1-53 and IMD1-53 receptors system is significantly up - regulated in myocardial fibrosis and such change maybe play a part in the procession of myocardial fibrosis.
出处 《宁夏医科大学学报》 2009年第3期281-284,F0002,共5页 Journal of Ningxia Medical University
基金 宁夏高等学校科学研究项目(宁高教[2006]237号)
关键词 Intermedin1-53 心肌纤维化 降钙素受体样受体 受体活性修饰蛋白 intermedin myocardial fibrosis calcitonin receptor - like receptor receptor - activity - modifying protein
  • 相关文献

参考文献10

  • 1Roh J, Chang CL, BhallaAetal. Intermedin is a calcitonin/calcitonin gene - related peptide family peptide acting through the calcitonin receptor - like receptor/receptor activity - modifying protein receptor complexes[J]. J Biol Chem, 2004,279 (8) : 7264 - 7274.
  • 2Olivetti G, Capasso JM, Meggs LG, et al. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats [J]. Circ Res,1991,68:856 -869.
  • 3Qi YF, Bu DF, da Niu D, et al. Effects of different pep tide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene [ J ]. Peptides, 2002,23(6) :1141 - 1147.
  • 4Shuji A. Role of angiotensin Ⅱ and endogenous vasodilators in the control of glomerular hemodynamics [ J ]. Clin Exp Nephrol,2003, (7) : 172 -178.
  • 5Pan CS, Yang JH, Cai DY, et al. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2[ J]. Peptides,2005,26(9) : 1640 - 1646.
  • 6Yang JH, Jia YX, Pan CS, et al. Effects of intermedin (1 -53 ) on cardiac function and ischemia/reperfusion injury in isolated rat hearts [ J ]. Biochem Biophys Res Commun, 2005,327(3) :713 -719.
  • 7Beltowski J, Jamroz A. AdrenomeduUin -what do we know 10 years since its discovery [ J ]. Pol J Pharmacol, 2004,56( 1 ) :5 - 27.
  • 8Yang JH, Qi YF, Jia YX, et al. Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts [ J ]. Peptides, 2005,26 ( 3 ) : 501 - 507.
  • 9Jia YX. Intermedinl -53 protects the heart against isoproterenol induced ischemic injuty in rats [ J ]. Eur J Pharmacol,2006,549( 1 - 3 ) : 117 - 123.
  • 10Fischer JA, Muff R, Born W. Functional relevance of G - protein - coupled - receptor - associated proteins, exemplified by receptor - activity - modifying proteins (RAMPs) [ J ]. Siochem Soc Trans, 2002, 30 (4) : 455 - 460.

同被引文献23

  • 1Rosenfeld MG, Mermod JJ, Amara SG, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissues- pecific RNA processing. Nature, 1983, 304: 129-135.
  • 2Shichiri M, Hirata Y. Regulation of cell growth and apoptosis by adrenomedullin. Hypertens Res, 2003, 26 (Suppl 1 ): S9-S14.
  • 3Roh J, Chang CL, Bhalla A, et al. Intermedin is a calci- tonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activi- tymodifying protein receptor complexes. J Biol Chem, 2004, 279: 7264-7274.
  • 4Takei Y, Inoue K, Ogoshi M, et al. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett, 2004, 556: 53-58.
  • 5Yang JH, Jia YX, Pan CS, et al. Effects of intermedin (1-5.3) on cardiac function and ischemia/repeffusion injury in isolated rat hearts. Biochem Biophys Res Commun, 2005, 327: 713-719.
  • 6Hirose T, Totstme K, Moil N, et al. Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure. Am J Physiol Renal Physiol, 2010, 299: F128-F134.
  • 7Takahashi K, Kikuchi K, Maruyama Y, et al. Immunocy- tochemical localization of adrenomedullin 2/intermedin-like immtmoreactivity in human hypothalamus, heart and kidney. Peptides,2006, 27: 1383-1389.
  • 8McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor- like receptor. Nature, 1998, 393: 333-339.
  • 9Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol, 2010, 6: 643-656.
  • 10Klahr S, Morfissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physioi, 2002, 283: F861-F875.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部